Top

Published in:

01-02-2004 | Poster presentation

Interim results of the SHARF4 study: outcome of acute renal failure with different treatment modalities

Authors: M Malbrain, M Elseviers, P Van der Niepen, P Damas, E Hoste, J Devriendt, R Lins

Published in: Critical Care | Special Issue 1/2004

Excerpt

It is important for ICU physicians to predict the mortality of acute renal failure (ARF) in the first 24–48 hours. For this the SHARF II score at 0 and 48 hours has been developed [1]. This study will look at short-term and long-term morbidity and mortality with different modes of treatment in ARF. …

Lins R, et al.: Clin Nephrol 2000, 53: 10-17.PubMed

Title: Interim results of the SHARF4 study: outcome of acute renal failure with different treatment modalities
Authors: M Malbrain
M Elseviers
P Van der Niepen
P Damas
E Hoste
J Devriendt
R Lins
Publication date: 01-02-2004
Publisher: BioMed Central
Published in: Critical Care / Issue Special Issue 1/2004
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc2620

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Interim results of the SHARF4 study: outcome of acute renal failure with different treatment modalities

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2004

Exosomes derived from plasma of septic patients induce myocardial dysfunction

Circulating thrombomodulin in ischemic heart disease: correlation with the extent and severity of coronary atherosclerosis

Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients

New diagnostic marker for sepsis: soluble CD14 subtype

Is there any place to corticotropin test in sepsis?

Management and outcome of patients with acute coronary syndrome in different units: predictors of outcome at the admission